When is antifibrinolytic therapy indicated in the treatment of DIC in sepsis/septic shock?

Updated: Oct 07, 2020
  • Author: Andre Kalil, MD, MPH; Chief Editor: Michael R Pinsky, MD, CM, Dr(HC), FCCP, FAPS, MCCM  more...
  • Print

In general, the BSCH does not recommend administering antifibrinolytic agents to patients with DIC. [111] In patients who have DIC that is characterized by a primary hyperfibrinolytic state and who present with severe bleeding, administration of lysine analogues (eg, tranexamic acid 1 g q8hr) may be considered.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!